Keywords: Sigma Pharma, Aspen Pharmacare, M&A

Sigma finally accepts takeover bid from Aspen, but only for its pharma division, with a price tag of A$900 million

Article | 16 August 2010

Print This

After several months of negations, starting with an offer that was later reduced, Australia’s troubled drugmaker Sigma Pharmaceuticals says ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in